FDA Unannounced Inspections in India Jump to 87%: What It Means for Indian Drugmakers
87% of FDA drug inspections in India were unannounced in fiscal 2026, up from 47%. What the surprise-audit shift means for Indian generic makers.
87% of FDA drug inspections in India were unannounced in fiscal 2026, up from 47%. What the surprise-audit shift means for Indian generic makers.